Jasper Therapeutics Inc

NASDAQ:JSPR   3:59:50 PM EDT
3.08
-0.08 (-2.53%)
Earnings Announcements

Jasper Therapeutics Reports First Quarter 2022 Results

Published: 05/12/2022 21:21 GMT
Jasper Therapeutics Inc (JSPR) - Jasper Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update.
Jasper Therapeutics Inc - to Initiate a New Study of Jsp191 As a Second-line Therapy for Patients With Lower-risk Mds Later This Year.
Jasper Therapeutics - Expects Current Cash & Cash Equivalents to Be Sufficient to Fund Its Planned Operating & Capital Expenditures Through Early 2023.
Jasper Therapeutics Inc - Qtrly Loss per Share $0.06.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.